Department of Surgery, University General Hospital, Avd. Obispo Torija, s/n, 13005, Ciudad Real, Spain.
Department of Anesthesiology, University General Hospital, Ciudad Real, Spain.
Clin Transl Oncol. 2019 Sep;21(9):1260-1269. doi: 10.1007/s12094-019-02052-8. Epub 2019 Feb 14.
In some patients with peritoneal carcinomatosis, we could perform the cytoreductive surgery and the HIPEC procedure by a complete laparoscopic approach to avoid morbidity. We consider that using laparoscopic approach for performing peritoneal carcinomatosis cytoreductive surgery and HIPEC with closed CO recirculation technique is possible and safe, with equal efficacy to conventional methods and hemodynamic complications.
Monitoring the effectiveness of the drug distribution in a laparoscopic ctoreductive and HIPEC surgery group with CO recirculation respect to a closed and open HIPEC group METHODS: Porcine model that included fifteen mini-pigs. Five pigs were operated with laparoscopic approach performing a pelvic and retroperitoneal lymphadenectomy. They later received a total laparoscopic closed HIPEC with CO recirculation (G1). Group 2 (G2): five pigs operated by an open cytoreductive surgery and closed HIPEC technique. Group 3 (G3): five animals in which an open cytoreductive surgery and an open HIPEC technique was performed. Blood and peritoneal determinations were realized after recirculation of the drug, at 60 min using chromatographic analysis.
G1-G2: phrenic right peritoneum, p: 0.46. Phrenic left peritoneum, p: 0.46. Pelvic peritoneum, p: 0.17. Serum paclitaxel: p: 0.01. G1-G3: phrenic right peritoneum, p: 0.34. Phrenic left peritoneum, p: 0.34. Pelvic peritoneum, p: 0.17. Serum paclitaxel G1-G3, p: 0.02.
A total laparoscopic approach for ctoreductive surgery and closed HIPEC with CO recirculation may be safe and feasible. In our experimental model there was no significant difference in tissue drug distribution respect the conventional techniques and there was a less toxicity because the serum drug concentration was significantly lower with laparoscopic approach respect the other groups.
在一些患有腹膜癌病的患者中,我们可以通过完全腹腔镜手术来进行细胞减灭术和 HIPEC 手术,以避免发病率。我们认为,使用腹腔镜方法进行腹膜癌病细胞减灭术和 HIPEC 手术,采用封闭 CO 再循环技术是可行且安全的,其疗效与传统方法相当,且无血液动力学并发症。
监测采用 CO 再循环的腹腔镜下肿瘤细胞减灭术和 HIPEC 手术组与封闭和开放 HIPEC 组之间药物分布的效果。
纳入了 15 头小型猪的猪模型。其中 5 头猪通过腹腔镜方法进行盆腔和腹膜后淋巴结清扫术。然后,它们接受了腹腔镜下封闭 CO 再循环的全腹腔镜下封闭 HIPEC(G1 组)。第 2 组(G2 组):5 头猪通过开放的肿瘤细胞减灭术和封闭 HIPEC 技术进行手术。第 3 组(G3 组):5 头动物接受了开放的肿瘤细胞减灭术和开放 HIPEC 技术。药物再循环后 60 分钟,使用色谱分析进行血液和腹膜测定。
G1-G2 组:右膈肌腹膜,p=0.46. 左膈肌腹膜,p=0.46. 骨盆腹膜,p=0.17. 血清紫杉醇,p=0.01. G1-G3 组:右膈肌腹膜,p=0.34. 左膈肌腹膜,p=0.34. 骨盆腹膜,p=0.17. 血清紫杉醇,G1-G3 组,p=0.02.
全腹腔镜方法进行肿瘤细胞减灭术和封闭 CO 再循环 HIPEC 可能是安全可行的。在我们的实验模型中,与传统技术相比,组织药物分布没有显著差异,并且由于腹腔镜方法与其他组相比,血清药物浓度显著降低,因此毒性较低。